XHKG
6699
Market cap1.22bUSD
May 30, Last price
56.30HKD
1D
0.54%
1Q
-8.75%
IPO
-85.18%
Name
Angelalign Technology Inc
Chart & Performance
P/E
99.40
P/S
4.48
EPS
0.52
Div Yield, %
3.91%
Shrs. gr., 5y
0.39%
Rev. gr., 5y
24.88%
Revenues
1.96b
+32.92%
Net income
88m
+65.35%
CFO
123m
-25.56%
Dividend
May 27, 20250.38 HKD/sh
Earnings
Jun 27, 2025
Profile
Angelalign Technology Inc., an investment holding company, engages in the research and development, manufacture, and marketing of clear aligner treatment solutions in China. Its products include Angel Aligner Pro and Angel Aligner Classic, which are custom made removable clear orthodontic aligners that move the patient's teeth into the proper position over time. The company also provides orthodontics and cosmetic dentistry services, and other dental services through its dental clinics, as well as sells intraoral scanners. It markets four lines of clear aligners, including Angelalign, Angelalign Pro, Angelalign Kid, and COMFOS. The company was founded in 2003 and is headquartered in Shanghai, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | |||||||
Revenues | 1,961,876 32.92% | 1,475,963 16.24% | 1,269,706 -0.15% | ||||
Cost of revenue | 1,993,328 | 1,501,604 | 1,114,894 | ||||
Unusual Expense (Income) | |||||||
NOPBT | (31,451) | (25,641) | 154,812 | ||||
NOPBT Margin | 12.19% | ||||||
Operating Taxes | 12,051 | 12,502 | 38,591 | ||||
Tax Rate | 24.93% | ||||||
NOPAT | (43,502) | (38,143) | 116,221 | ||||
Net income | 88,420 65.35% | 53,475 -74.99% | 213,781 -25.21% | ||||
Dividends | (173,986) | (105,966) | (176,044) | ||||
Dividend yield | 1.75% | 1.11% | 0.85% | ||||
Proceeds from repurchase of equity | (949) | (34,413) | |||||
BB yield | 0.01% | 0.36% | |||||
| Debt | |||||||
Debt current | 51,356 | 28,661 | 13,346 | ||||
Long-term debt | 135,630 | 84,543 | 43,062 | ||||
Deferred revenue | 86,931 | ||||||
Other long-term liabilities | 454,939 | 433,329 | |||||
Net debt | (3,426,209) | (2,847,286) | (3,728,643) | ||||
| Cash flow | |||||||
Cash from operating activities | 123,477 | 165,872 | 146,870 | ||||
CAPEX | (200,255) | (97,972) | (95,389) | ||||
Cash from investing activities | (1,013,284) | (981,706) | (159,774) | ||||
Cash from financing activities | (207,730) | (187,061) | (193,612) | ||||
FCF | (195,827) | (176,651) | 41,231 | ||||
| Balance | |||||||
Cash | 3,188,415 | 3,439,626 | 3,649,376 | ||||
Long term investments | 424,780 | (479,136) | 135,675 | ||||
Excess cash | 3,515,101 | 2,886,692 | 3,721,566 | ||||
Stockholders' equity | 473,092 | 707,713 | 584,118 | ||||
Invested Capital | 3,592,845 | 3,198,503 | 3,040,415 | ||||
ROIC | 3.69% | ||||||
ROCE | 4.27% | ||||||
| EV | |||||||
Common stock shares outstanding | 169,043 | 168,720 | 168,810 | ||||
Price | 58.90 4.16% | 56.55 -54.02% | 123.00 -50.20% | ||||
Market cap | 9,956,651 4.36% | 9,541,110 -54.05% | 20,763,691 -47.32% | ||||
EV | 6,575,250 | 6,864,334 | 17,030,479 | ||||
EBITDA | 82,844 | 59,576 | 220,037 | ||||
EV/EBITDA | 79.37 | 115.22 | 77.40 | ||||
Interest | 8,024 | 1,676 | |||||
Interest/NOPBT | 1.08% | ||||||